Zomedica Pharmaceuticals (ZOM) Receives a Buy from Noble Financial
Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Zomedica Pharmaceuticals (ZOM – Research Report) today and set a price target ...
EQS-News: GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs
Financial GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs 05.02.2025 / 15:06 CET/CEST The issuer is solely responsible for the content of this ...
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs
Mpox, Oncology Therapies and AI Integration Positions GeoVax for Strong Momentum ATLANTA, GA - February 5, 2025 (NEWMEDIAWIRE ...
GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor Conference
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and ...